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Silver-Russel syndrome (SRS) is a congenital developmental disorder characterized by 
intrauterine and postnatal growth failure, relative macrocephaly, protruding forehead, body 
asymmetry, and feeding difficulties. Hypomethylation of the H19 differentially methylated 
region (DMR) on chromosome 11p15.5 is the most common cause of the SRS phenotype. We 
report the first SRS patient with hypomethylation of the H19-DMR and maternally-derived 
15q11.2-q13.1 duplication. Although her clinical manifestations overlapped with those of 
previously reported SRS cases, the patient’s intellectual disability and facial dysmorphic 
features were inconsistent with the SRS phenotype. Methylation analyses, array comparative 
genomic hybridization, and a FISH analysis revealed the hypomethylation of the H19-DMR 
and a maternally-derived interstitial 5.7-Mb duplication at 15q11.2-q13.1 encompassing the 
Prader-Willi/Angelman critical region in the patient. Based on the genetic and clinical 
findings in the present and previously reported cases, it is unlikely that the 15q duplication in 
the patient led to the development of hypomethylation of the H19-DMR and it is reasonable 
to consider that the characteristic phenotype in the patient was caused by the coexistence of 
the two (epi)genetic conditions. Further studies are needed to clarify the mechanisms leading 
to methylation aberrations in SRS. 
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Silver-Russel syndrome (SRS) is a congenital developmental disorder characterized by 
intrauterine and postnatal growth failure, relative macrocephaly, protruding forehead, body 
asymmetry, and feeding difficulties (OMIM 180860). SRS is mainly caused by the 
hypomethylation of the H19-differentially methylated region (DMR) on chromosome 
11p15.5 and maternal uniparental chromosome 7 (upd[7]mat), which account for ~40% and 
5-10% of SRS patients, respectively. In addition, several other (epi)genetic aberrations, 
including 14q32 abnormalities, a heterozygous 15q26.3 deletion, and multi-locus imprinting 
disturbance have been identified in a small fraction of SRS-like patients.1-3 
15q11.2-q13.1 duplication syndrome is characterized by hypotonia, motor delays, 
intellectual disability, autism spectrum disorder (ASD), and epilepsy (OMIM 608636).4 This 
condition is caused by the presence of at least one extra maternally-derived copy of the 
Prader-Willi/Angelman critical region (PWACR) within chromosome 15q11.2-q13.1, 
whereas individuals with paternally-derived 15q11-q13 duplication are unlikely to develop 
symptoms.5,6  
We herein report the clinical and genetic findings in the first SRS patient with a 
maternally-derived 15q11.2-q13.1 duplication, and discuss the relationship between 
hypomethylation of the H19-DMR and 15q11.2-q13.1 duplication in the patient. 
 
CASE REPORT 
A Japanese girl was born at 39 weeks’ gestation. At birth, her body length was 37.5 cm 
(–5.0 s.d.), her body weight was 1.47 kg (–5.0 s.d.) and her occipitofrontal circumference was 
34.5 cm (+1.0 s.d.). She was diagnosed with SRS in infancy because the clinical features 
satisfied five of the six key features in the Netchine–Harbison SRS clinical scoring system 
(prenatal growth retardation, relative macrocephaly, protruding forehead, body asymmetry, 




and feeding difficulties). 7 She also had dysmorphic facial features (upturned nose, 
down-slanting palpebral fissures, hypertelorism, and low-set ears), which are observed less 
frequently in patients with SRS (Figure 1a and b; Table 1). She had severe hypotonia and 
failure to thrive in infancy. Her motor development was obviously delayed; she held up her 
head at 9 months, rolled over at 10 months, and walked at 2 years and 6 months.  
At 9 years of age, treatment with a long-acting gonadotropin-releasing hormone 
analog was initiated because she entered puberty with severe short stature (-4.8 s.d.); however, 
the therapy had only modest effects on her growth (Figure 1c). At the last examination, at 15 
years of age, she measured 131.2 cm (final adult height, -5.0 s.d.) and weighed 21 kg 
(-4.0 s.d.). She had intellectual disability (total IQ, 67).  
Her non-consanguineous parents and elder sister were clinically normal. Her father 
and mother were 180 cm (+0.6 s.d.) and 152 cm (–1.3 s.d.) tall, respectively. There was no 
family history of seizure, neurodevelopmental diseases, or congenital malformation. 
 
MOLECULAR STUDIES 
This study was approved by the Institutional Review Board Committee at the National Center 
for Child Health and Development. DNA was obtained from peripheral blood samples from 
the patient and her parents after obtaining written informed consent. 
First, we performed pyrosequencing-based methylation analyses for two DMRs 
responsible for SRS (H19-DMR and PEG1/MEST-DMR on chromosome 7), as previously 
reported.8,9 The results showed profound hypomethylation of the H19-DMR in the patient. 
Subsequently, we performed methylation analyses for other DMRs related to known 
imprinting disorders to search for multilocus imprinting disturbance, and found mild 
hypermethylation of the SNRPN-DMR at 15q11.2 (Figure 2a and Supplementary Table 1). 
Because the patient’s intellectual disability and facial dysmorphic features were 




inconsistent with the SRS phenotype, we performed oligoarray comparative genomic 
hybridization using a human catalog array (2x400K format, ID G4448A; Agilent 
Technologies, Santa Clara, CA, USA) to identify other mechanisms leading to the phenotype. 
This revealed a 5.7-Mb duplication at 15q11.2-q13.1 encompassing the PWACR (Figure 2b). 
The duplication was also identified in the patient’s mother. Fluorescence in situ hybridization 
with an SNRPN probe for PWACR detected two signals with a marked difference in intensity 
(a normal signal and an intense signal), indicating that this was an interstitial tandem 
duplication (Figure 2c). A methylation analysis of the mother revealed mild hypomethylation 
at the SNRPN DMR in contrast to the results in the patient (Figure 2a and Supplementary 
Table 1).  
 
DISCUSSION 
We identified hypomethylation of the H19-DMR and a maternally-derived 
15q11.2-q13.1 duplication in a patient with SRS. The patient had typical SRS manifestations 
as well as intellectual disability and dysmorphic facial features, which are common in 
patients with 15q11.2-q13.1 duplication syndrome, but not in SRS patients (Figure 1 and 
Table 1).10-12 These findings imply that the characteristic phenotype in the patient was likely 
caused by the coexistence of two rare epigenetic and genetic conditions. 
The genetic basis for the development of H19-DMR hypomethylation in SRS 
patients remains to be explored.1,3 No unambiguous genomic aberrations in patients with 
hypomethylation of the H19-DMR have been identified thus far.1,13,14 In this regard, it is 
unlikely that the 15q11.2-q13.1 duplication in the present patient led to the development of 
hypomethylation of the H19-DMR for the following reasons. First, although over 30 different 
copy number variations have been reported in patients with the SRS phenotype, 
15q11.2-q13.1 duplications have not been reported in SRS patients.1,13-15 Second, although 
patients with 15q11.2-q13.1 duplication show methylation abnormalities of the SNRPN-DMR, 




those of the H19-DMR or other DMRs have not been reported in those patients. Third, the 
major manifestations seen in SRS patients (postnatal growth failure, relative macrocephaly, 
clinodactyly, and body asymmetry) have rarely (or never) been detected in patients with 
15q11.2-q13.1 duplications.10-12 Taken together, the two rare (epi)genetic conditions seemed 
to co-exist in the patient by chance. 
The phenotypically normal mother also had the same 15q duplication. In this regard, 
since the duplicated region including the PWACR is imprinted, almost all of the previously 
reported children who inherit the duplicated allele from their mothers develop symptoms, 
whereas those who inherit it from their fathers are unlikely to develop symptoms.6, 10-12 
Hypomethylation at the SNRPN DMR, which is methylated on the maternal allele, indicates 
the paternal origin of the duplication in the mother.3 These findings are consistent with the 
normal phenotype of the mother. 
In conclusion, we reported the first case of H19-DMR hypomethylation and 
maternally-derived interstitial 15q11.2-q13.1 duplication. Further studies are needed to 
clarify the mechanisms leading to the epimutation in SRS patients. 
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TITLES AND FIGURE LEGENDS 
Figure 1. The clinical findings in the patient. 
The patient had dysmorphic facial features, including an upturned nose, down-slanting 
palpebral fissures, micrognathia, and relative macrocephaly (a), and severe clinodactyly of 
the bilateral fifth fingers (b). c, The growth chart of the patient. GnRHa, 
gonadotropin-releasing hormone analog. 
 
Figure 2. Molecular studies of the family.  
a. Methylation analyses. Methylation indices obtained by pyrosequencing for nine DMRs. 
Red and black lines indicate methylation indices of the patient and the mother, 
respectively.  Gray vertical bars indicate the reference ranges (minimum-maximum) in 
50 control subjects. 
b. Oligoarray CGH analyses of the family. The duplication at chromosome 15q11.2-q13.1 
was 5.7 Mbp in physical size (highlighted in yellow). Please note that a small deletion 
identified in upstream region of the 15q11.2-q13.1 duplication in the proband and the 
father (white arrows) has been reported as a normal copy number variant 
(http://dgv.tcag.ca/dgv/app/home). 
c. Fluorescence in situ hybridization analysis. A ~125-kb probe identifying a region 
encompassing SNRPN (red signals) was hybridized to lymphocyte metaphase spreads, 
together with a probe for D15Z1 on 15p11.2 (blue signals, small arrows) and a probe for 
PML on 15q22 (green signals, arrow heads) utilized as internal controls.  
 
Table 1 Clinical features of the present and reported cases with H19 -DMR hypomethylation.
Present case
SRS with H19 -DMR
hypomethylationc
Growth parameters
Prenatal growth failurea + +
Birth weight (SD) –5.0 SD –3.50±0.85 (n = 42)
Birth length (SD) –5.0 SD –4.13±2.01 (n = 31)
Birth OFC (SD)  +1.0 SD –0.54±1.22 (n = 29)
Postnatal growth failurea + +
present height (SD) –5.0 SD –3.58±1.65 (n = 35)
present weight (SD) –4.0 SD –3.15±1.16 (n = 32)
present OFC –0.5 SD –1.16±1.18 (n = 21)
SRS phenotype
Relative macrocepahaly at birtha + 100.0%
Protruding foreheada + 83.8%
Body asymmetrya + 81.1%
Feeding difficultya, b + 47.1%
Trianglluar face + 97.7%
Clinodactyly + 78.4%
Brachydactyly + 78.9%
Simian crease – 15.4%
Irregular teeth + 46.2%
ear anomaliesb + 40.0%
Muscular hypotoniab + 53.1%
Speech delayb – 25.8%
Developmental delayb + 48.6%
Scoliosis/Kyphosisb + N.D.
15q duplication phenotype
Mental retardation + (IQ 67) N.D.
Autism – N.D.
Learning disablity + N.D.
Bhavioral disturbance – N.D.
Epilepsy – N.D.
Upturned nose + N.D.
Flattened nasal bridge + N.D.
High-arched palate + N.D.
Epicanthic fold – N.D.
Downslanting palpebral fissures + N.D.
Reduced sikin pipmentation – N.D.
a Key features in the Netchine–Harbison SRS clinical scoring system. b Manifestations
overlapping with those of 15q duplication syndrome. c Frequencies of clinical features in
Japanese patients with H19 -DMR hypomethylation reported by Fuke et al. SRS, Silver
Russel syndrome; IG-DMR, intergenic differentially methylated region; SD, standard
deviation; OFC, occipitofrontal circumference; +, present; -, absent; N.D., not described.
Supplementary Table 1. Methylation indices (%) for CpG dinucleotides at disease-associated DMRs
Conrol (n=50)
Median (Min-Max)
PLAGL1(ZAC1)-DMR 1 50 48 47 (33-52)
(Ch. 6q24.2) 2 49 45 46 (34-51)
3 48 48 48 (40-56)
4 39 37 39 (31-47)
5 40 46 50 (44-58)
6 46 48 49 (41-55)
7 56 50 53 (47-58)
PEG1 -DMR 8 59 53 60 (56-70)
(Ch. 7q32.2) 9 58 53 59 (55-69)
10 55 51 58 (52-68)
11 60 57 61 (42-73)
12 56 52 57 (47-66)
13 60 53 60 (54-70)
PEG10 -DMR 14 56 55 56 (50-59)
(Ch. 7q21.3) 15 46 51 55 (50-59)
16 54 53 53 (48-59)
17 55 52 54.5 (50-59)
18 50 50 50 (45-55)
H19 -DMR 19 21 42 48 (37-60)
(Ch. 11p15.5) 20 21 44 50 (39-64)
21 19 41 46 (36-57)
22 18 41 45 (36-55)
23 19 35 45.5 (37-55)
24 21 41 47 (38-58)
25 21 43 46.5 (38-54)
26 18 36 42.5 (37-55)
Kv -DMR 27 51 53 58 (49-66)
(Ch. 11p15.5) 28 53 57 61 (52-68)
29 46 51 48 (41-54)
30 49 55 48 (42-55)
31 56 59 67 (55-72)
32 57 60 64 (55-71)
IG-DMR 33 62 55 58 (49-68)
(Ch. 14q32.2) 34 59 54 54 (40-62)
35 71 66 68 (54-78)
36 55 53 53.5 (43-64)
MEG3 -DMR 37 52 50 52 (43-56)
(Ch. 14q32.2) 38 55 51 55 (52-65)
39 50 50 37 (32-55)
40 57 52 60 (44-74)
41 45 45 36 (26-47)
SNRPN -DMR 42 64 39 55 (50-60)
(Ch. 15q11.2) 43 58 35 49 (44-54)
44 59 37 51 (46-57)
45 59 37 52 (47-57)
46 72 49 63 (58-68)
GNAS  A/B-DMR 47 45 43 41 (34-45)
(Ch. 20q13.32) 48 43 42 40 (33-45)
49 45 44 43 (35-47)
50 43 40 38 (32-42)
51 43 41 40 (33-45)
52 43 40 38 (31-42)
53 44 42 40 (32-44)
DMR CpG# Proband Mother
The hypomethylated and hypermethylated CpG sites are highlighted with light
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